patent infringement Illumina, Qiagen, Columbia University Near Settlement in Patent Infringement Case It is unclear whether the impending settlement will affect all the litigation between the two sides, across several legal venues. US Appeals Court Rejects Bio-Rad's 'Zombie' Claims to 10x Genomics' Single-Cell Patents The ruling came as part of a decision to uphold a US International Trade Commission finding that Bio-Rad imported and sold infringing products. US Appeals Court Upholds Invalidation of Columbia University Sequencing Chemistry Patents The appellate court's decision deals a blow to a 2017 Columbia University lawsuit that alleged Illumina infringed one of the invalidated patents. Natera Sues Inivata, Alleging Infringement of Cancer Testing Patents Natera alleges Inivata infringes its US Patent Nos. 10,262,755 and 10,597,709, which cover cancer monitoring and molecular residual disease testing. BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud In their complaint the plaintiffs claimed Illumina fraudulently obtained two US patents by concealing a reference from the patent office. Dec 2, 2020 Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents Oct 7, 2020 Natera Sues Genosity for Patent Infringement Relating to ArcherDx Products Oct 5, 2020 Federal Court Rejects ArcherDx Motion Against Natera in Patent Infringement Lawsuit Sep 11, 2020 Patent Board Rules Broad Institute First With Functioning CRISPR System in Eukaryotic Cells Aug 14, 2020 In Brief This Week: BGI, Illumina, Pacific Biosciences, Oxford Nanopore, Co-Diagnostics, More Aug 13, 2020 BioSpyder Seeks Noninfringement Judgment in HTG Molecular Patent Dispute Aug 3, 2020 US Appeals Court Lifts Injunction on 10x Genomics' Linked-Reads, Single-Cell CNV Assays Jul 10, 2020 AbCellera Biologics Files Patent Infringement Suit Against Berkeley Lights Jul 7, 2020 Progenity Asks Court to Declare Non-Infringement of Natera Patents Jun 17, 2020 Natera Sues Progenity, Alleging Noninvasive Prenatal Test Infringes Patents Jun 2, 2020 Ravgen Sues Natera Over Cell-Free DNA Genetic Testing Patents May 19, 2020 Personal Genomics Sues Pacific Biosciences in Chinese Court for Patent Infringement Apr 15, 2020 Natera Expands IP Lawsuit Against ArcherDx With Three New Patents Apr 9, 2020 CareDx, Stanford Sue TAI Diagnostics for Patent Infringement Mar 18, 2020 Jury Invalidates Pacific Biosciences Patents in Lawsuit Against Oxford Nanopore Mar 17, 2020 CareDx, Stanford Add Third Patent to IP Lawsuit Against Natera Mar 12, 2020 Jury Rules in Favor of Hologic, Grifols in BioMérieux Patent Infringement Lawsuit Feb 27, 2020 Illumina Sues BGI Again, Alleging New CoolMPS Chemistry Infringes SBS Patents Feb 6, 2020 Court Strikes BGI Defenses in Suit Against Illumina; Partly Upholds Patent Infringement Claim Jan 27, 2020 Natera Sues ArcherDx for Infringement of New Target Amplification Patent Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.